- ￥1338 - 9188
- abinScience
- China
- VK137013
- 2026年03月10日
- Alpaca
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
企业认证
相关产品推荐更多 >
Anti-Human CD171/L1CAM Antibody (OV52.24), PerCP, 抗人CD171/L1CAM抗体 (OV52.24), PerCP标记
询价
Anti-Human CD304/NRP1 Antibody (SAA0097), PerCP, 抗人CD304/NRP1抗体 (SAA0097), PerCP标记
询价Anti-Npas4 Antibody (N408/79), 抗Npas4抗体 (N408/79)
￥1176Anti-Human KRT12 Polyclonal Antibody, 抗人KRT12多克隆抗体
￥1008
Research Grade Dupilumab, 研究级Dupilumab
￥2288
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- 保质期：
1 year
- 抗原来源：
Alpaca
- 目录编号：
VK137013
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Alpaca
- 靶点：
Guanine-N7 methyltransferase nsp14, Non-structural protein 14, Proofreading exoribonuclease nsp14, nsp14
- 规格：
50ug/100ug/1mg
| 规格： | 50ug | 产品价格： | ￥1338.0 |
|---|---|---|---|
| 规格： | 100ug | 产品价格： | ￥2288.0 |
| 规格： | 1mg | 产品价格： | ￥9188.0 |
| Product name | Anti-SARS-CoV-2 nsp14 Nanobody (SAA2774) |
|---|---|
| Catalog No. | VK137013 |
| Host species | Alpaca |
| Species reactivity | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) |
| Immunogen | \ |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Clonality | Monoclonal |
| Isotype | VHH-His |
| Applications | ELISA |
| Target | Guanine-N7 methyltransferase nsp14, Non-structural protein 14, Proofreading exoribonuclease nsp14, nsp14 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Accession | P0DTD1 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Clone ID | SAA2774 |
| Note | For research use only. |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product quality.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验凋亡”途径，使得从小鼠中获取较多数量的活性细胞比较困难，也成为这类研究的桎梏。 为此，研发人员推出了Treg-ProtectorTM（anti-ARTC Nanobody）产品，该纳米抗体能够有效抑制NAD+与 ARTC2的结合，从而抑制因损伤等刺激性条件引起NAD+诱导的细胞凋亡途径，从而提高活性细胞的数量。研究结果表明，将这种纳米抗体注射到小鼠体内能有助于收集活性Treg细胞的数量，就像获取NK细胞的方法一样, 实验结果可以观察到注射了Treg-ProtectorTM小鼠的脾脏细胞中Treg的细胞
＞(5-8)×108／kg，CFU-GM＞ (20-50) ×104／kg，CD34+细胞＞ (2.0-50) x106／kg，可以作为PBSCT植活所需的参考阈值。 如何进行外周血造血干细胞的动员? 正常情况下，外周血中的干／祖细胞的含量占单个核细胞的 0.01％—0.1％相当于骨髓的1％—10％，动员后外周血MNC中CD34+细胞数及CFU—删数均明显高于骨髓。迄今已发现多聚阴离子化合物(如硫酸葡聚糖)、糖皮质激素、细菌内毒素、抗肿瘤药物、四氢叶酸以及造血生长因子等均能有效地动员骨髓
素-1(Cardiotrophin-1) 48T/96T 2000/3000 进口分装 F0035 Caspase-1 48T/96T 2000/3000 进口分装 F0036 Caspase-2 48T/96T 2000/3000 进口分装 F0037 Caspase-3 48T/96T 2000/3000 进口分装 F0038 Caspase-10 48T/96T 2000/3000 进口分装 F0039 CD14 48T/96T 2000/3000 进口
技术资料暂无技术资料 索取技术资料
